Through the above analysis, we have found that SELENBP1 mRNA expression levels are associated with immune infiltration in the tumor microenvironment, and that CRC patients with low SELENBP1 mRNA expression levels have shorter OS than those with low SELENBP1 mRNA expression levels. This evidence concerns the gene SELENBP1 and colorectal carcinoma.